Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Extended Tranexamic Acid After Total Knee Arthroplasty
NCT06618820Phase 3Enrolling by invitation
- Sponsor
- Campbell Clinic Orthopaedics
- Start
- Sep 2024
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of tranexamic acid in osteoarthritis (OA) (3 arms), sponsored by Campbell Clinic Orthopaedics. Primary endpoints: Forgotten Joint Score - Knee at 1 year and Range of Motion at 1 year. Started Sep 2024; status: enrolling by invitation.
02
Drugs
tranexamic acid
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06618820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06618820.